Grifols SA
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
430 / 1361
Position in country
208 / 287
Return on Assets, %
0.8
-40.3
Net income margin, %
4.3
-180
EBITDA margin, %
18.9
-168.2
Debt to Equity, %
173.6
3.2
Intangible assets and goodwill, %
44.9
0.2
Revenue CAGR 3Y, %
7.2
12.5
Total Equity change 1Y, %
-2
-9
Revenue Y, % chg
12.3
0
P/E
68.3
31
P/BV
0.7
1.8
P/S
0.6
10.3
EV/S
2.6
7.5
EV/EBITDA
15
-1.6
Average Analyst recommendation
Hold
Hold
Average upside forecasts, %
141.3
131.1
Forward P/E
6.9
21.4
Dividend Yield, %
9.8
1.1
Forward Dividend Yield, %
2.6
0.1
Expected dividend per share
0.1
0
Payout Ratio, %
0
0
Dividend Ex Date
2021-06-03
Competitors
Ranks
-
Vertex Pharmaceuticals Inc
00%
-
CSL Ltd
00%
-
Regeneron Pharmaceuticals Inc
00%
-
Gilead Sciences Inc
00%
-
Seagen Inc
00%
-
Amgen Inc
00%
-
Celltrion Inc
00%
-
Grifols SA
00%
-
Moderna Inc
00%
-
AbbVie Inc
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
Spain
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Sub-sector
Health Care
Capitalization (millions of $)
5602.5
Ticker
GRFS.OQ
ISIN
US3984384087
IPO date
2006-05-17
Availability on Russian exchanges
No
Reporting for
2024-03-08
Date fact. publication of reports
2023-12-31
Company Description
Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. It organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Bio Supplies provides, mostly, biological products for non-therapeutic use. Others provides manufacturing services to third party companies.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: